<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Progranulin is an important molecule in <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> is frequently associated with central <z:hpo ids='HP_0001513'>obesity</z:hpo> and associated disturbances; however, the role of circulating progranulin in human <z:hpo ids='HP_0001513'>obesity</z:hpo>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>RESEARCH DESIGN AND METHODS: For the measurement of progranulin serum concentrations, we developed an enzyme-linked immunosorbent assay (ELISA) </plain></SENT>
<SENT sid="3" pm="."><plain>Using this ELISA, we assessed circulating progranulin in a cross-sectional study of 209 subjects with a wide range of <z:hpo ids='HP_0001513'>obesity</z:hpo>, body fat distribution, insulin sensitivity, and <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance and in 60 individuals with <z:mpath ids='MPATH_458'>normal</z:mpath> (NGT) or impaired (IGT) <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> before and after a 4-week physical training program </plain></SENT>
<SENT sid="4" pm="."><plain>Progranulin <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression was measured in paired samples of omental and subcutaneous adipose tissue (adipocytes and cells of the stromal vascular fraction) from 55 lean or <z:mp ids='MP_0001261'>obese</z:mp> individuals </plain></SENT>
<SENT sid="5" pm="."><plain>Measurement of Erk activation and chemotactic activity induced by progranulin in vitro was performed using <z:chebi fb="0" ids="46941">THP</z:chebi>-1-based cell migration assays </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Progranulin serum concentrations were significantly higher in individuals with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> compared with NGT and in <z:mp ids='MP_0001261'>obese</z:mp> subjects with predominant visceral fat accumulation </plain></SENT>
<SENT sid="7" pm="."><plain>Circulating progranulin significantly correlates with BMI, macrophage infiltration in omental adipose tissue, C-reactive protein (CRP) serum concentrations, A1C values, and total cholesterol </plain></SENT>
<SENT sid="8" pm="."><plain>Multivariable linear regression analyses revealed CRP levels as the strongest independent predictor of circulating progranulin </plain></SENT>
<SENT sid="9" pm="."><plain>The extent of in vitro progranulin-mediated chemotaxis is similar to that of monocyte chemoattractant protein-1 but independent of Galpha </plain></SENT>
<SENT sid="10" pm="."><plain>Moreover, in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, but not in IGT and NGT individuals, physical training for 4 weeks resulted in significantly decreased circulating progranulin levels </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Elevated progranulin serum concentrations are associated with visceral <z:hpo ids='HP_0001513'>obesity</z:hpo>, elevated plasma <z:chebi fb="105" ids="17234">glucose</z:chebi>, and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>We identified progranulin as a novel marker of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> in <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> that closely reflects omental adipose tissue macrophage infiltration </plain></SENT>
<SENT sid="13" pm="."><plain>Physical training significantly reduces elevated circulating progranulin in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>